Search results
- 3.3712Add to watchlist+0.0912 (+2.77%)As of Tue. May 14, 2024 10:30 AM EDT · Nasdaq Real Time Price (USD) · Market open
- Open3.2500High3.4438Low3.2450
- Mkt Cap74.9MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close3.280052 Wk. Low0.170052 Wk. High9.7700
Related stocks
10.20. +9.44%. Find the latest Tempest Therapeutics, Inc. (TPST) stock quote, history, news and other vital information to help you with your stock trading and investing.
5 days ago · Tempest Therapeutics Inc. Watch list. NEW. Set a price target alert. After Hours. Last Updated: May 10, 2024 7:48 p.m. EDT Delayed quote. $ 3.3100. 0.06 1.85% After Hours Volume: 3.78K. Advanced...
Discover real-time Tempest Therapeutics, Inc. Common Stock (TPST) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with...
4 days ago · Their TPST share price targets range from $13.00 to $47.00. On average, they expect the company's share price to reach $25.00 in the next twelve months. This suggests a possible upside of 669.2% from the stock's current price. View analysts price targets for TPST or view top-rated stocks among Wall Street analysts.
- (415) 798-8589
- 110 MILLER AVENUE SUITE 100, ANN ARBOR MI, 48104
- stephanie@sternir.com
People also ask
What are TPST share price targets?
What does TPST stand for?
Should you buy Tempest Therapeutics (TPST) stock?
Does NASDAQ use TPST stock to determine compliance with listing requirements?
May 1, 2024 · A high-level overview of Tempest Therapeutics, Inc. (TPST) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
- Corvus Pharmaceuticals, Inc.
- Biotechnology
- 28
- 68.65M
Get the latest Tempest Therapeutics Inc (TPST) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Per-Share Earnings, Actuals and Estimates. View the latest Tempest Therapeutics Inc. (TPST) stock price, news, historical charts, analyst ratings and financial information from WSJ.